Company / Depreciation & Amortization
Apellis Pharmaceuticals, Inc. Depreciation & Amortization History
FY2019-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$240.0K
FY2019
5-year range
-
FY2019-FY2019
Trend
-
vs FY2018
Sector context
#153 of 168
Health Care
What the data says
Among 168 Health Care companies, Apellis Pharmaceuticals, Inc. is in the top 9% for depreciation & amortization.
Based on SEC 10-K filings.
$240,000 in FY2019.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 168This company $240.0K Sector average $212.9M
▼
-99.9% below sector average
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $240.0K | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Feb 28, 2026